Akoya Biosciences(us:AKYA)

    2.49

    -2.35%

    Updated on 2024-12-22

    Open:2.46
    Close:2.49
    High:2.60
    Low:2.34
    Pre Close:2.55
    Volume:365652.00
    Amount:908314.88
    Turnover:0.74%
    Shares:49.56M
    MarketCap:123.41M

    About Akoya Biosciences Company

    Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.

    Company Name: Akoya Biosciences
    Company Address: 100 Campus Drive,6th Floor
    Employees: 330
    Fiscar Year: 12-31
    IPO Date: 2021-04-16
    CIK: 1711933

    View all SEC Filings

    About

    Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
    Address:100 Campus Drive,6th Floor

    Market Movers